KIM PURCELL-REID: Open Payments
NPI 1396739330 · CHINA GROVE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,950 in 168 payments from 25 companies in 2025. Trend: 2023 $3,297 · 2024 $3,506 · 2025 $2,950
Food & beverage: $2,851Education: $99
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $397 |
| ABBVIE INC. | 30 | $385 |
| Novo Nordisk Inc | 17 | $265 |
| PFIZER INC. | 14 | $237 |
| GlaxoSmithKline, LLC. | 11 | $189 |
| Astellas Pharma US Inc | 6 | $186 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $172 |
| Bayer Healthcare Pharmaceuticals Inc. | 13 | $146 |
| Lilly USA, LLC | 7 | $121 |
| Otsuka America Pharmaceutical, Inc. | 5 | $112 |
Products named: FARXIGA, TRELEGY ELLIPTA, VRAYLAR, CAPLYTA, AIRSUPRA, Kerendia, Wegovy, JARDIANCE.
Industry payments across NC — which companies pay providers there.
